SCHEMBL30989861

SCHEMBL30989861

CN(Cc1cccc(OC(F)(F)F)c1)C(=O)c1cc(Cl)cnc1OC(F)F

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RIPK1 Q13546 2/20 0.49
▸ PTGER4 P35408 1/20 0.45
▸ TRPM8 Q7Z2W7 2/20 0.41
▸ CETP P11597 2/20 0.41
▸ SLC6A9 P48067 5/20 0.41
▸ KCNH2 Q12809 3/20 0.41
▸ ATM Q13315 1/20 0.41
▸ KDM5A P29375 1/20 0.40
▸ KDM4C Q9H3R0 1/20 0.40
▸ KDM5B Q9UGL1 1/20 0.40
▸ POLB P06746 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ RECQL P46063 1/20 0.39
▸ ROCK2 O75116 1/20 0.39
▸ ROCK1 Q13464 1/20 0.39
▸ CYP2D6 P10635 2/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ SLC6A5 Q9Y345 1/20 0.39
▸ CNR1 P21554 1/20 0.39
▸ HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30989812 0.93 MEP1B (0.44) RIPK1POLBHPGDRECQLROCK2
SCHEMBL30989922 0.90 POLB (0.49) RIPK1POLBHPGDRECQLROCK2
SCHEMBL30989806 0.88 GRM5 (0.45) RIPK1HPGDRECQLHTT
SCHEMBL30989807 0.88 TACR1 (0.47) PTGER4HPGDPDK1
SCHEMBL30989923 0.86 ALDH1A1 (0.47) RIPK1PTGER4HPGDHTT
SCHEMBL30989857 0.86 HSP90AA1 (0.52) HTTPDK1
SCHEMBL30989865 0.83 PTGER4 (0.41) PTGER4CNR1HTTPDK1
SCHEMBL30989808 0.80 HTT (0.39) PTGER4ATMHPGDHTT
SCHEMBL30989793 0.78 HTT (0.38) PTGER4HPGDHTT
SCHEMBL30989822 0.78 RIPK1 (0.42) RIPK1PTGER4ATMPOLBHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612131-A1 NICOTINAMIDE DERIVATIVES FOR USE IN TREATING DISORDERS ASSOCIATED WITH KCNK13 ACTIVITY Cerevance, Inc. (US) 2025-09-10 — — EP disclosed
WO-2024095003-A1 NICOTINAMIDE DERIVATIVES FOR USE IN TREATING DISORDERS ASSOCIATED WITH KCNK13 ACTIVITY Cerevance, Inc. (US) 2024-05-10 — — WO disclosed
Send feedback